Brought to you by 
Abbott splits, spins off AbbVie
Mar 2016
Executive Summary
As of January 1, 2013, Abbott Laboratories Inc. will split into two separate, publicly traded health care companies by spinning off AbbVie Inc. Abbott will focus on diversified medical products--nutritionals (28%), devices (27%), generics (25%), and diagnostics (20%)--and AbbVie will become a research-based pharmaceutical firm that sells pharmaceuticals and biologics in the US and worldwide.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Divestiture/Spin-Out
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott splits, spins off AbbVie
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice